Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1998 Jun 1;101(11):2340–2350. doi: 10.1172/JCI1615

An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.

A M Salmon 1, C Bruand 1, A Cardona 1, J P Changeux 1, S Berrih-Aknin 1
PMCID: PMC508823  PMID: 9616205

Abstract

Myasthenia gravis (MG) is an autoimmune disease targeting the skeletal muscle acetylcholine receptor (AChR). Although the autoantigen is present in the thymus, it is not tolerated in MG patients. In addition, the nature of the cell bearing the autoantigen is controversial. To approach these questions, we used two lineages of transgenic mice in which the beta-galactosidase (beta-gal) gene is under the control of a 842-bp (Tg1) or a 3300-bp promoter fragment (Tg2) of the chick muscle alpha subunit AChR gene. In addition to expression in muscle cells, thymic expression was observed in both mouse lines (mainly in myoid cells in Tg1 and myoid cells and epithelial cells in Tg2). After challenge with beta-gal, Tg1 mice produced Th2-dependent anti-beta-gal antibodies, while Tg2 mice were almost unresponsive. By contrast, in a proliferation assay both Tg lines were unresponsive to beta-gal. Cells from Tg1 mice produce Th2-dependent cytokine whereas cells from Tg2 mice were nonproducing in response to beta-gal. These data indicate that the level of expression in Tg1 mice could be sufficient to induce tolerance of Th1 cells but not of Th2 cells, while both populations are tolerated in Tg2 mice. These findings are compatible with the hypothesis that AChR expression is not sufficiently abundant in MG thymus to induce a full tolerance.

Full Text

The Full Text of this article is available as a PDF (9.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelstein S., Pritchard-Briscoe H., Anderson T. A., Crosbie J., Gammon G., Loblay R. H., Basten A., Goodnow C. C. Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science. 1991 Mar 8;251(4998):1223–1225. doi: 10.1126/science.1900950. [DOI] [PubMed] [Google Scholar]
  2. Barkas T., Gabriel J. M., Mauron A., Hughes G. J., Roth B., Alliod C., Tzartos S. J., Ballivet M. Monoclonal antibodies to the main immunogenic region of the nicotinic acetylcholine receptor bind to residues 61-76 of the alpha subunit. J Biol Chem. 1988 Apr 25;263(12):5916–5920. [PubMed] [Google Scholar]
  3. Berrih-Aknin S., Morel E., Raimond F., Safar D., Gaud C., Binet J. P., Levasseur P., Bach J. F. The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann N Y Acad Sci. 1987;505:50–70. doi: 10.1111/j.1749-6632.1987.tb51282.x. [DOI] [PubMed] [Google Scholar]
  4. Berrih S., Morel E., Gaud C., Raimond F., Le Brigand H., Bach J. F. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis. Neurology. 1984 Jan;34(1):66–71. doi: 10.1212/wnl.34.1.66. [DOI] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Charpak G., Dominik W., Zaganidis N. Optical imaging of the spatial distribution of beta-particles emerging from surfaces. Proc Natl Acad Sci U S A. 1989 Mar;86(6):1741–1745. doi: 10.1073/pnas.86.6.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drachman D. B. Myasthenia gravis. N Engl J Med. 1994 Jun 23;330(25):1797–1810. doi: 10.1056/NEJM199406233302507. [DOI] [PubMed] [Google Scholar]
  8. Dubois-Dauphin M., Theler J. M., Zaganidis N., Dominik W., Tribollet E., Pévet P., Charpak G., Dreifuss J. J. Expression of vasopressin receptors in hamster hypothalamus is sexually dimorphic and dependent upon photoperiod. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11163–11167. doi: 10.1073/pnas.88.24.11163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Egwuagu C. E., Charukamnoetkanok P., Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J Immunol. 1997 Oct 1;159(7):3109–3112. [PubMed] [Google Scholar]
  10. Engel E. K., Trotter J. L., McFarlin D. E., McIntosh C. L. Thymic epithelial cell contains acetylcholine receptor. Lancet. 1977 Jun 18;1(8025):1310–1311. doi: 10.1016/s0140-6736(77)91343-5. [DOI] [PubMed] [Google Scholar]
  11. Fambrough D. M., Drachman D. B., Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science. 1973 Oct 19;182(4109):293–295. doi: 10.1126/science.182.4109.293. [DOI] [PubMed] [Google Scholar]
  12. Gammon G., Sercarz E. E., Benichou G. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoire. Immunol Today. 1991 Jun;12(6):193–195. doi: 10.1016/0167-5699(91)90052-U. [DOI] [PubMed] [Google Scholar]
  13. Geuder K. I., Schoepfer R., Kirchner T., Marx A., Müller-Hermelink H. K. The gene of the alpha-subunit of the acetylcholine receptor: molecular organisation and transcription in myasthenia-associated thymomas. Thymus. 1989;14(1-3):179–186. [PubMed] [Google Scholar]
  14. Hara Y., Ueno S., Uemichi T., Takahashi N., Yorifuji S., Fujii Y., Tarui S. Neoplastic epithelial cells express alpha-subunit of muscle nicotinic acetylcholine receptor in thymomas from patients with myasthenia gravis. FEBS Lett. 1991 Feb 11;279(1):137–140. doi: 10.1016/0014-5793(91)80268-8. [DOI] [PubMed] [Google Scholar]
  15. Husby S., Mestecky J., Moldoveanu Z., Holland S., Elson C. O. Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol. 1994 May 1;152(9):4663–4670. [PubMed] [Google Scholar]
  16. Iwabuchi K., Nakayama K., McCoy R. L., Wang F., Nishimura T., Habu S., Murphy K. M., Loh D. Y. Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes. Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9000–9004. doi: 10.1073/pnas.89.19.9000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jermy A., Beeson D., Vincent A. Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur J Immunol. 1993 Apr;23(4):973–976. doi: 10.1002/eji.1830230433. [DOI] [PubMed] [Google Scholar]
  18. Kaminski H. J., Fenstermaker R. A., Abdul-Karim F. W., Clayman J., Ruff R. L. Acetylcholine receptor subunit gene expression in thymic tissue. Muscle Nerve. 1993 Dec;16(12):1332–1337. doi: 10.1002/mus.880161210. [DOI] [PubMed] [Google Scholar]
  19. Kao I., Drachman D. B. Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis. Science. 1977 Jan 7;195(4273):74–75. doi: 10.1126/science.831257. [DOI] [PubMed] [Google Scholar]
  20. Kappler J. W., Roehm N., Marrack P. T cell tolerance by clonal elimination in the thymus. Cell. 1987 Apr 24;49(2):273–280. doi: 10.1016/0092-8674(87)90568-x. [DOI] [PubMed] [Google Scholar]
  21. Kisielow P., Blüthmann H., Staerz U. D., Steinmetz M., von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature. 1988 Jun 23;333(6175):742–746. doi: 10.1038/333742a0. [DOI] [PubMed] [Google Scholar]
  22. Klarsfeld A., Bessereau J. L., Salmon A. M., Triller A., Babinet C., Changeux J. P. An acetylcholine receptor alpha-subunit promoter conferring preferential synaptic expression in muscle of transgenic mice. EMBO J. 1991 Mar;10(3):625–632. doi: 10.1002/j.1460-2075.1991.tb07990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Klarsfeld A., Changeux J. P. Activity regulates the levels of acetylcholine receptor alpha-subunit mRNA in cultured chicken myotubes. Proc Natl Acad Sci U S A. 1985 Jul;82(13):4558–4562. doi: 10.1073/pnas.82.13.4558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kuks J. B., Oosterhuis H. J., Limburg P. C., The T. H. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations. J Autoimmun. 1991 Apr;4(2):197–211. doi: 10.1016/0896-8411(91)90018-8. [DOI] [PubMed] [Google Scholar]
  25. Le Brigand H., Levasseur P., Miranda A. R., Gaud C., Wojakowski I. Résultats du traitement chirurgical de la myasthénie (248 cas de thymectomies). Ann Chir. 1980 Mar;34(3):169–172. [PubMed] [Google Scholar]
  26. Leprince C., Cohen-Kaminsky S., Berrih-Aknin S., Vernet-Der Garabedian B., Treton D., Galanaud P., Richard Y. Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis. J Immunol. 1990 Oct 1;145(7):2115–2122. [PubMed] [Google Scholar]
  27. Lindstrom J. M., Lennon V. A., Seybold M. E., Whittingham S. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann N Y Acad Sci. 1976;274:254–274. doi: 10.1111/j.1749-6632.1976.tb47691.x. [DOI] [PubMed] [Google Scholar]
  28. Lindstrom J. M., Seybold M. E., Lennon V. A., Whittingham S., Duane D. D. Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value. Neurology. 1976 Nov;26(11):1054–1059. doi: 10.1212/wnl.26.11.1054. [DOI] [PubMed] [Google Scholar]
  29. Link H., Olsson O., Sun J., Wang W. Z., Andersson G., Ekre H. P., Brenner T., Abramsky O., Olsson T. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest. 1991 Jun;87(6):2191–2196. doi: 10.1172/JCI115253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Marx A., Kirchner T., Hoppe F., O'Connor R., Schalke B., Tzartos S., Müller-Hermelink H. K. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol. 1989 Apr;134(4):865–877. [PMC free article] [PubMed] [Google Scholar]
  31. Marx A., Kirchner T., Hoppe F., O'Connor R., Schalke B., Tzartos S., Müller-Hermelink H. K. Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis. Am J Pathol. 1989 Apr;134(4):865–877. [PMC free article] [PubMed] [Google Scholar]
  32. Marx A., O'Connor R., Geuder K. I., Hoppe F., Schalke B., Tzartos S., Kalies I., Kirchner T., Müller-Hermelink H. K. Characterization of a protein with an acetylcholine receptor epitope from myasthenia gravis-associated thymomas. Lab Invest. 1990 Mar;62(3):279–286. [PubMed] [Google Scholar]
  33. Müller S., Weihe E. Interrelation of peptidergic innervation with mast cells and ED1-positive cells in rat thymus. Brain Behav Immun. 1991 Mar;5(1):55–72. doi: 10.1016/0889-1591(91)90007-w. [DOI] [PubMed] [Google Scholar]
  34. Nossal G. J. Negative selection of lymphocytes. Cell. 1994 Jan 28;76(2):229–239. doi: 10.1016/0092-8674(94)90331-x. [DOI] [PubMed] [Google Scholar]
  35. Oehen S. U., Ohashi P. S., Bürki K., Hengartner H., Zinkernagel R. M., Aichele P. Escape of thymocytes and mature T cells from clonal deletion due to limiting tolerogen expression levels. Cell Immunol. 1994 Oct 15;158(2):342–352. doi: 10.1006/cimm.1994.1281. [DOI] [PubMed] [Google Scholar]
  36. Ohashi P. S., Oehen S., Buerki K., Pircher H., Ohashi C. T., Odermatt B., Malissen B., Zinkernagel R. M., Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 1991 Apr 19;65(2):305–317. doi: 10.1016/0092-8674(91)90164-t. [DOI] [PubMed] [Google Scholar]
  37. Ohshima F., Kondo K., Tsubaki T. Binding of iodine 125 alpha-bungarotoxin to the thymus of mice. Arch Neurol. 1978 Jan;35(1):31–32. doi: 10.1001/archneur.1978.00500250035007. [DOI] [PubMed] [Google Scholar]
  38. Ohtsuru I., Matsuo H., Fukudome T., Suenaga A., Tsujihata M., Nagataki S. 'Split tolerance' induction by intrathymic injection of acetylcholine receptor in a rat model of autoimmune myasthenia gravis; implications for the design of specific immunotherapies. Clin Exp Immunol. 1995 Dec;102(3):462–467. doi: 10.1111/j.1365-2249.1995.tb03838.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Oukka M., Colucci-Guyon E., Tran P. L., Cohen-Tannoudji M., Babinet C., Lotteau V., Kosmatopoulos K. CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity. 1996 Jun;4(6):545–553. doi: 10.1016/s1074-7613(00)80481-1. [DOI] [PubMed] [Google Scholar]
  40. Piette J., Klarsfeld A., Changeux J. P. Interaction of nuclear factors with the upstream region of the alpha-subunit gene of chicken muscle acetylcholine receptor: variations with muscle differentiation and denervation. EMBO J. 1989 Mar;8(3):687–694. doi: 10.1002/j.1460-2075.1989.tb03427.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pircher H., Brduscha K., Steinhoff U., Kasai M., Mizuochi T., Zinkernagel R. M., Hengartner H., Kyewski B., Müller K. P. Tolerance induction by clonal deletion of CD4+8+ thymocytes in vitro does not require dedicated antigen-presenting cells. Eur J Immunol. 1993 Mar;23(3):669–674. doi: 10.1002/eji.1830230315. [DOI] [PubMed] [Google Scholar]
  42. Plaut M. Lymphocyte hormone receptors. Annu Rev Immunol. 1987;5:621–669. doi: 10.1146/annurev.iy.05.040187.003201. [DOI] [PubMed] [Google Scholar]
  43. Posselt A. M., Barker C. F., Tomaszewski J. E., Markmann J. F., Choti M. A., Naji A. Induction of donor-specific unresponsiveness by intrathymic islet transplantation. Science. 1990 Sep 14;249(4974):1293–1295. doi: 10.1126/science.2119056. [DOI] [PubMed] [Google Scholar]
  44. Pugliese A., Zeller M., Fernandez A., Jr, Zalcberg L. J., Bartlett R. J., Ricordi C., Pietropaolo M., Eisenbarth G. S., Bennett S. T., Patel D. D. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 1997 Mar;15(3):293–297. doi: 10.1038/ng0397-293. [DOI] [PubMed] [Google Scholar]
  45. Remuzzi G., Rossini M., Imberti O., Perico N. Kidney graft survival in rats without immunosuppressants after intrathymic glomerular transplantation. Lancet. 1991 Mar 30;337(8744):750–752. doi: 10.1016/0140-6736(91)91368-5. [DOI] [PubMed] [Google Scholar]
  46. Rinner I., Kukulansky T., Felsner P., Skreiner E., Globerson A., Kasai M., Hirokawa K., Korsatko W., Schauenstein K. Cholinergic stimulation modulates apoptosis and differentiation of murine thymocytes via a nicotinic effect on thymic epithelium. Biochem Biophys Res Commun. 1994 Sep 15;203(2):1057–1062. doi: 10.1006/bbrc.1994.2289. [DOI] [PubMed] [Google Scholar]
  47. Salmon A. M., Changeux J. P. Regulation of an acetylcholine receptor LacZ transgene by muscle innervation. Neuroreport. 1992 Nov;3(11):973–976. doi: 10.1097/00001756-199211000-00006. [DOI] [PubMed] [Google Scholar]
  48. Schluep M., Willcox N., Vincent A., Dhoot G. K., Newsom-Davis J. Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study. Ann Neurol. 1987 Aug;22(2):212–222. doi: 10.1002/ana.410220205. [DOI] [PubMed] [Google Scholar]
  49. Singh R. R., Hahn B. H., Sercarz E. E. Neonatal peptide exposure can prime T cells and, upon subsequent immunization, induce their immune deviation: implications for antibody vs. T cell-mediated autoimmunity. J Exp Med. 1996 Apr 1;183(4):1613–1621. doi: 10.1084/jem.183.4.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Tominaga K., Kinoshita Y., Hato F., Masudå A., Matsuyama M. Effects of cholinergic agonists on the proliferation and protein synthesis in a cultured thymic epithelial cell line. Cell Mol Biol. 1989;35(6):679–686. [PubMed] [Google Scholar]
  51. Tria M. A., Vantini G., Fiori M. G., Rossi A. Choline acetyltransferase activity in murine thymus. J Neurosci Res. 1992 Feb;31(2):380–386. doi: 10.1002/jnr.490310221. [DOI] [PubMed] [Google Scholar]
  52. Tzartos S. J., Seybold M. E., Lindstrom J. M. Specificities of antibodies to acetylcholine receptors in sera from myasthenia gravis patients measured by monoclonal antibodies. Proc Natl Acad Sci U S A. 1982 Jan;79(1):188–192. doi: 10.1073/pnas.79.1.188. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Vafiadis P., Bennett S. T., Todd J. A., Nadeau J., Grabs R., Goodyer C. G., Wickramasinghe S., Colle E., Polychronakos C. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 1997 Mar;15(3):289–292. doi: 10.1038/ng0397-289. [DOI] [PubMed] [Google Scholar]
  54. Wakkach A., Guyon T., Bruand C., Tzartos S., Cohen-Kaminsky S., Berrih-Aknin S. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J Immunol. 1996 Oct 15;157(8):3752–3760. [PubMed] [Google Scholar]
  55. Wekerle H., Ketelsen U. P., Zurn A. D., Fulpius B. W. Intrathymic pathogenesis of myasthenia gravis: transient expression of acetylcholine receptors on thymus-derived myogenic cells. Eur J Immunol. 1978 Aug;8(8):579–582. doi: 10.1002/eji.1830080808. [DOI] [PubMed] [Google Scholar]
  56. Wheatley L. M., Urso D., Tumas K., Maltzman J., Loh E., Levinson A. I. Molecular evidence for the expression of nicotinic acetylcholine receptor alpha-chain in mouse thymus. J Immunol. 1992 May 15;148(10):3105–3109. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES